Add BrightSurf on Google Email

Work-life imbalance significantly increases risk of cardiovascular diseases

A recent study found that work-life imbalance significantly predicts higher triglycerides and lower HDL levels in midlife and older adults. This suggests that spillover effects of workplace stress on home life can contribute to physiological changes linked to cardiovascular diseases. The research highlights the importance of organizati...

SourceSingapore Management University·JournalJournal of Psychosomatic Research·DateMay 31, 2024

Proteomic signatures may indicate MRI-assessed liver fat

Researchers from Ben-Gurion University of the Negev have discovered a link between proteomic biomarkers and liver fat percentage, which may improve patient monitoring and therapy targeting for NAFLD. The study, conducted over 18 months, found that specific protein changes were independently associated with liver fat relative change.

SourceBen-Gurion University of the Negev·JournalHepatology·TypeRandomized controlled/clinical trial·DateMay 28, 2024

Can triglycerides-HDL-C ratio, HOMA-IR, ApoB, non-HDL cholesterol, and free cholesterol be laboratory-associated flags of female coronary atherosclerosis regardless of being diabetic?

Research finds insulin levels correlate with triglycerides, ApoB, non-HDL cholesterol, and free cholesterol in women with atherosclerotic coronary disease. The study suggests these laboratory-associated flags indicate early coronary atherosclerosis in both diabetic and non-diabetic women.

SourceBentham Science Publishers·JournalThe Open Biomarkers Journal·DateMay 24, 2024

Researchers develop “game-changing” blood test for stroke detection

Researchers developed a game-changing blood test that can quickly and accurately identify large vessel occlusion strokes, which have the potential to bring life-saving care to patients globally. The test combines biomarkers with a clinical score to detect strokes with 93% specificity and 81% sensitivity.

SourceBrigham and Women's Hospital·JournalStroke Vascular and Interventional Neurology·TypeExperimental study·DateMay 17, 2024

Researchers identify new marker for breast cancer prognosis

Researchers found elevated expression of RPGRIP1L in invasive breast cancer specimens, correlating with shorter survival times and unfavorable clinicopathological features. The study identified 50 genes and 15 proteins related to RPGRIP1L expression, including those involved in immune response and metabolism.

SourceWiley·JournalThe FASEB Journal·DateMay 15, 2024

Cyclin D1 expression in penile cancer

Researchers found cyclin D1 expression in patients with penile cancer (PC) is associated with clinical and histopathological features. Patients with cyclin D1 expression had lower disease-free survival compared to the cyclin D1-negative group.

SourceImpact Journals LLC·JournalOncotarget·TypeObservational study·DateMay 15, 2024

Massive study identifies new biomarkers for renal cancer subtypes, improving diagnosis and—eventually—treatment

A massive study identifies new biomarkers for renal cell carcinoma subtypes, improving diagnosis and treatment. The researchers' integrative analysis of proteogenomic datasets reveals molecular features shared by clear cell and non-clear cell RCC tumors, as well as unique features to various subtypes.

SourceMichigan Medicine - University of Michigan·JournalCell Reports Medicine·TypeExperimental study·DateMay 6, 2024

A blood test for stroke risk? Study finds network of inflammatory molecules may act as biomarker for risk of future cerebrovascular disease

Researchers at UCLA Health have developed a potential biomarker for stroke risk using a network of inflammatory molecules in the blood. The study, published in the journal Stroke, found that patients with higher concentrations of these molecules had an 84% chance of experiencing a stroke during their lifetime.

SourceUniversity of California - Los Angeles Health Sciences·JournalStroke·TypeData/statistical analysis·DateMay 1, 2024

Researchers identify biomarkers in blood to predict liver cancer

A new study suggests that proteins detectable in the blood could improve predictions about risk of liver cancer, potentially leading to earlier therapeutic interventions. The researchers used proteomics to develop a prediction model and identified 56 plasma proteins associated with liver cancer.

SourceMass General Brigham·JournalJNCI Journal of the National Cancer Institute·TypeExperimental study·DateMay 1, 2024

Study finds biomarkers for psychiatric symptoms in patients with rare genetic condition 22q

A recent study led by UC Davis Health researchers provides new insights into the molecular changes linked to 22q11.2 deletion syndrome, a rare genetic condition that can lead to psychosis, ADHD, and other conditions. The study identified two biomarkers, taurine and arachidonic acid, which could predict likelihood of psychosis in patien...

Alzheimer’s drug development pipeline: Positive results, new insight on biomarkers position 2024 as ‘learning year’

The Alzheimer's disease treatment landscape is experiencing a significant shift, with numerous potential drugs making their way through clinical trials. Biomarkers have also emerged as a key area of focus, providing valuable information on the drug's impact and allowing for more precise guidance in future trials.

SourceUniversity of Nevada, Las Vegas·JournalAlzheimer s & Dementia Translational Research & Clinical Interventions·TypeSystematic review·DateApr 24, 2024

Study suggests racial discrimination during midlife associated with Alzheimer’s disease pathology later in life

A new study found a link between midlife racial discrimination and increased levels of Alzheimer's disease markers, including phosphorylated tau181 and neurofilament light, in older age. Researchers analyzed data from 255 Black Americans over 17 years, revealing that chronic stress from racism contributed to dementia risk.

SourceAtrium Health Wake Forest Baptist·JournalAlzheimer s & Dementia·DateApr 10, 2024

Hope for treating autoimmune diseases

A routine blood test that measures inflammation levels could improve diagnosis and management of debilitating autoimmune diseases. The Systemic Inflammation Index (SII) has shown high accuracy in diagnosing immunological diseases.

SourceFlinders University·JournalClinical and Experimental Medicine·TypeSystematic review·DateApr 2, 2024

Soluble immune checkpoint factors in blood as potential biomarkers of therapeutic efficacy for ICI cancer immunotherapy and assessing t-cell exhaustion

Researchers developed a novel assay to study immune checkpoint molecules in blood plasma, finding elevated concentrations in patients with immune-reactive tumors who were nonresponsive to PD-1/PD-L1 blockade therapy. Soluble factors correlated with exhausted antitumor immunity and predicted therapy efficacy.

SourceKindai University·JournalJournal of Clinical Investigation·TypeRandomized controlled/clinical trial·DateApr 1, 2024

NIST researchers use cellphone compass to measure tiny concentrations of compounds important for human health

Researchers at NIST have developed a method using cellphone magnetometers to rapidly and cheaply measure biomedical properties for monitoring or diagnosing diseases, including glucose levels in saliva. The technique has the potential to detect environmental toxins and measure biomarkers such as histamines with high sensitivity.

SourceNational Institute of Standards and Technology (NIST)·JournalNature Communications·TypeExperimental study·DateApr 1, 2024

Best way to bust deepfakes? Use AI to find real signs of life, say Klick Labs scientists

Researchers at Klick Labs developed an algorithm to detect deepfakes with 80% accuracy by analyzing speech pause patterns, offering a solution to the growing problem of AI-generated content. The study's findings suggest that vocal biomarkers can distinguish between real and fake voices, providing a novel approach to flagging deepfakes.

SourceKlick Applied Sciences·JournalJMIR Biomedical Engineering·TypeData/statistical analysis·DateMar 21, 2024

NTU Singapore scientists invent a coin-sized device to rapidly isolate blood plasma for diagnostics and precision medicine

Researchers at NTU Singapore have created a chip that can directly isolate blood plasma from a tube of blood in just 30 minutes, removing over 99.9% of blood cells and platelets. The device, called ExoArc, enables high-quality plasma for disease screening and research, improving diagnosis accuracy and reducing waiting times.

SourceNanyang Technological University·JournalACS Nano·TypeRandomized controlled/clinical trial·DateMar 21, 2024

Genetic test identifies patients with triple negative breast cancer who are unlikely to respond to immunotherapies

A new genetic test has identified patients with triple negative early-stage breast cancer who are unlikely to respond to immunotherapy drugs. The test, called ImPrintTN, can predict a patient's likelihood of responding to these treatments and help avoid severe side effects.

SourceEuropean Organisation for Research and Treatment of Cancer·TypeRandomized controlled/clinical trial·DateMar 19, 2024

Water droplet spun by sound screens for colon cancer

Researchers at Duke University have developed a new diagnostic platform that uses sound waves to spin an individual drop of water up to 6,000 revolutions per minute. The technique separates tiny biological particles within samples to enable new diagnostics based on exosomes.

SourceDuke University·JournalScience Advances·TypeExperimental study·DateMar 13, 2024